๐๏ธ OncologyCapsule
Nilotinib
Nilotinib
A BCR-ABL tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive chronic myeloid leukemia in newly diagnosed patients or those resistant to or intolerant of imatinib.
Form
Capsule
Uses
2
Side effects
6
Category
Oncology
01
What is Nilotinib used for?
- Treatment of newly diagnosed Ph+ CML in chronic phase
- Treatment of chronic or accelerated phase Ph+ CML resistant to or intolerant of prior imatinib therapy
02
Nilotinib side effects
Common side effects of Nilotinib include:
Myelosuppression
QT prolongation
Rash
Nausea
Headache
Elevated liver enzymes
CommonModerateLess common
03
Nilotinib warnings & precautions
- Prolongs QT interval; sudden deaths have been reported
- Obtain baseline ECG and monitor periodically; correct hypokalemia and hypomagnesemia before treatment
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Nilotinib in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.